{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T04:29:48Z","timestamp":1692851388248},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To describe variation in incidence and mortality rates of cervical cancer (CC), between 4 Southern European countries that share similar cultural characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data on CC incidence and mortality reported in Portugal, Spain, Italy, and Greece for the year 2012 were obtained through the International Agency of Research on Cancer. Expected numbers of incident cases and deaths were obtained based on age-specific rates in European region. Standardized incidence rate (SIR) and standardized mortality rate (SMR) and respective 95% confidence interval (95% CI) were computed for each country by age group (15\u201339, 40\u201354, 55\u201364, and \u226565 years old).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The number of incident cases of and deaths due to CC observed in Greece, Italy, and Spain were significantly lower than expected, whichever the age group. In Portugal such pattern was, however, only found for incident cases among women aged up to 54 years. The number of incident cases observed in Portugal did not differ from that expected among women aged 55 to 64 (SIR\u200a=\u200a90.8; 95% CI: 76.8\u2013106.7) and aged 65 or more years (SIR\u200a=\u200a110.0; 95% CI: 95.9\u2013125.0). Also, the number of deaths observed in Portugal did not differ from that expected among women aged 15 to 39 (SMR\u200a=\u200a70.0; 95% CI: 43.3\u2013100.8), 40 to 54 (SMR\u200a=\u200a93.6; 95% CI: 74.9\u2013115.4), and 55 to 64 years (SMR\u200a=\u200a93.6; 95% CI: 73.4\u2013117.7) but was significantly higher than that expected among women aged 65 or more years (SMR\u200a=\u200a126.7; 95% CI: 110.1\u2013144.4).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>There is variability in CC incidence and mortality between 4 South European countries. To understand the reasons underlying such variability could improve approach to preventive care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1016\/j.pbj.0000000000000026","type":"journal-article","created":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T17:35:42Z","timestamp":1538501742000},"page":"e26","source":"Crossref","is-referenced-by-count":2,"title":["Incidence and mortality due to cervical cancer in 4 south European countries"],"prefix":"10.1097","volume":"4","author":[{"given":"Cristina","family":"Teixeira","sequence":"first","affiliation":[{"name":"Escola Superior de Sa\u00fade do Instituto Polit\u00e9cnico de Bragan\u00e7a, Bragan\u00e7a"},{"name":"EPI-Unit, Instituto de Sa\u00fade P\u00fablica, Universidade do Porto, Porto"}]},{"given":"Ana","family":"Afonso","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade do Instituto Polit\u00e9cnico de Bragan\u00e7a, Bragan\u00e7a"}]},{"given":"Luciana","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade do Instituto Polit\u00e9cnico de Bragan\u00e7a, Bragan\u00e7a"}]},{"given":"Muriela","family":"Madureira","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade do Instituto Polit\u00e9cnico de Bragan\u00e7a, Bragan\u00e7a"}]},{"given":"Ant\u00f3nio","family":"Nogueira","sequence":"additional","affiliation":[{"name":"Escola Superior de Sa\u00fade do Instituto Polit\u00e9cnico de Bragan\u00e7a, Bragan\u00e7a"},{"name":"Departamento de Ci\u00eancias Veterin\u00e1rias, CITAB, Universidade de Tr\u00e1s-os-Montes e Alto Douro (UTAD), Vila Real, Portugal."}]}],"member":"276","reference":[{"key":"R2-20230824","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R3-20230824","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/2046-4053-2-35","article-title":"Screening for cervical cancer: a systematic review and meta-analysis","volume":"2","author":"Peirson","year":"2013","journal-title":"Syst Rev"},{"issue":"(suppl 8)","key":"R5-20230824","doi-asserted-by":"crossref","first-page":"I1","DOI":"10.1016\/j.vaccine.2013.07.026","article-title":"Comprehensive control of human papillomavirus infections and related diseases","volume":"31","author":"Bosch","year":"2013","journal-title":"Vaccine"},{"key":"R6-20230824","first-page":"CD001035","article-title":"Interventions for encouraging sexual behaviours intended to prevent cervical cancer","author":"Shepherd","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R8-20230824","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Global Health"},{"key":"R9-20230824","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.28722","article-title":"State of the science in cervical cancer: where we are today and where we need to go","volume":"120","author":"Dizon","year":"2014","journal-title":"Cancer"},{"key":"R10-20230824","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5306\/wjco.v7.i5.406","article-title":"Factors associated with cervical cancer screening in a safety net population","volume":"7","author":"Heberer","year":"2016","journal-title":"World J Clin Oncol"},{"key":"R11-20230824","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12889-017-4115-0","article-title":"Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study","volume":"17","author":"Trapero-Bertran","year":"2017","journal-title":"BMC Public Health"},{"key":"R12-20230824","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/eurpub\/ckt077","article-title":"Cytology use for cervical cancer screening in Portugal: results from the 2005\/2006 National Health Survey","volume":"24","author":"Oliveira","year":"2014","journal-title":"Eur J Public Health"}],"container-title":["Porto Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02054639-201902000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T01:54:13Z","timestamp":1692842053000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/02054639-201902000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1016\/j.pbj.0000000000000026","relation":{},"ISSN":["2444-8664"],"issn-type":[{"value":"2444-8664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}